CEO’s Insider Buying Signals Confidence in Volatile Zenas Biopharma
CEO insider buying fuels optimism for Zenas Biopharma’s volatile stock – a calculated 100k‑share spree that signals confidence amid clinical‑trial uncertainty.
4 minutes to read
Zenas Biopharma Inc